According to Rigel Pharmaceuticals's latest financial reports the company's current earnings are S$0.15 Billion. In 2023 the company made an earning of -S$24.69 Million, an increase over its 2022 earnings that were of -S$74.33 Million. The earnings displayed on this page is the company's Pretax Income.